GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Price-to-Funds-From-Operations

MGX (Metagenomi) Price-to-Funds-From-Operations : (As of Apr. 08, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Metagenomi Business Description

Industry
Traded in Other Exchanges
N/A
Address
5959 Horton Street, Emeryville, CA, USA, 94608
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).